Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2006989376', 'doi': 'https://doi.org/10.1016/j.beem.2009.08.001', 'title': 'Tyrosine kinase inhibitors and the thyroid', 'display_name': 'Tyrosine kinase inhibitors and the thyroid', 'publication_year': 2009, 'publication_date': '2009-11-27', 'ids': {'openalex': 'https://openalex.org/W2006989376', 'doi': 'https://doi.org/10.1016/j.beem.2009.08.001', 'mag': '2006989376', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/19942148'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.beem.2009.08.001', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S63781308', 'display_name': 'Best Practice & Research Clinical Endocrinology & Metabolism', 'issn_l': '1521-690X', 'issn': ['1521-690X', '1532-1908'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5084622735', 'display_name': 'Steven I. Sherman', 'orcid': 'https://orcid.org/0000-0002-3079-5153'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Steven I. Sherman', 'raw_affiliation_strings': ['Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, Division of Internal Medicine, The University of Texas M. D. Anderson Cancer Center, PO Box 301402, Houston, TX 77230-1402, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, Division of Internal Medicine, The University of Texas M. D. Anderson Cancer Center, PO Box 301402, Houston, TX 77230-1402, USA', 'institution_ids': ['https://openalex.org/I1343551460']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5084622735'], 'corresponding_institution_ids': ['https://openalex.org/I1343551460'], 'apc_list': {'value': 4030, 'currency': 'USD', 'value_usd': 4030, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.806, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 46, 'citation_normalized_percentile': {'value': 0.399524, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 94, 'max': 95}, 'biblio': {'volume': '23', 'issue': '6', 'first_page': '713', 'last_page': '722'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10952', 'display_name': 'mTOR Signaling in Growth and Disease', 'score': 0.9952, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10952', 'display_name': 'mTOR Signaling in Growth and Disease', 'score': 0.9952, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10329', 'display_name': 'Management and Diagnosis of Thyroid Cancer', 'score': 0.9925, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10583', 'display_name': 'The p53 Signaling Network in Cancer Research', 'score': 0.9922, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/cancer-therapy', 'display_name': 'Cancer Therapy', 'score': 0.595944}, {'id': 'https://openalex.org/keywords/vandetanib', 'display_name': 'Vandetanib', 'score': 0.58869725}, {'id': 'https://openalex.org/keywords/tumor-suppression', 'display_name': 'Tumor Suppression', 'score': 0.52898}, {'id': 'https://openalex.org/keywords/thyroid-nodules', 'display_name': 'Thyroid Nodules', 'score': 0.511375}, {'id': 'https://openalex.org/keywords/medullary-thyroid-cancer', 'display_name': 'Medullary Thyroid Cancer', 'score': 0.510753}, {'id': 'https://openalex.org/keywords/differentiated-thyroid-cancer', 'display_name': 'Differentiated Thyroid Cancer', 'score': 0.510106}], 'concepts': [{'id': 'https://openalex.org/C2779490328', 'wikidata': 'https://www.wikidata.org/wiki/Q417542', 'display_name': 'Sunitinib', 'level': 3, 'score': 0.87260705}, {'id': 'https://openalex.org/C2778695046', 'wikidata': 'https://www.wikidata.org/wiki/Q421136', 'display_name': 'Sorafenib', 'level': 3, 'score': 0.834516}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8013511}, {'id': 'https://openalex.org/C2779761222', 'wikidata': 'https://www.wikidata.org/wiki/Q826522', 'display_name': 'Thyroid cancer', 'level': 3, 'score': 0.5889722}, {'id': 'https://openalex.org/C2780333294', 'wikidata': 'https://www.wikidata.org/wiki/Q7914515', 'display_name': 'Vandetanib', 'level': 4, 'score': 0.58869725}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.52342296}, {'id': 'https://openalex.org/C2993294228', 'wikidata': 'https://www.wikidata.org/wiki/Q13632630', 'display_name': 'Thyroid carcinoma', 'level': 3, 'score': 0.5226954}, {'id': 'https://openalex.org/C2780394083', 'wikidata': 'https://www.wikidata.org/wiki/Q539568', 'display_name': 'Angiogenesis', 'level': 2, 'score': 0.50974554}, {'id': 'https://openalex.org/C526584372', 'wikidata': 'https://www.wikidata.org/wiki/Q16399', 'display_name': 'Thyroid', 'level': 2, 'score': 0.4970055}, {'id': 'https://openalex.org/C42362537', 'wikidata': 'https://www.wikidata.org/wiki/Q87099740', 'display_name': 'Tyrosine kinase', 'level': 3, 'score': 0.4901081}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.4860471}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.48390493}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.46786168}, {'id': 'https://openalex.org/C2780120053', 'wikidata': 'https://www.wikidata.org/wiki/Q3493538', 'display_name': 'Medullary thyroid cancer', 'level': 4, 'score': 0.45574972}, {'id': 'https://openalex.org/C2993291352', 'wikidata': 'https://www.wikidata.org/wiki/Q16399', 'display_name': 'Thyroid function', 'level': 3, 'score': 0.4507246}, {'id': 'https://openalex.org/C2778820342', 'wikidata': 'https://www.wikidata.org/wiki/Q906415', 'display_name': 'Tyrosine-kinase inhibitor', 'level': 3, 'score': 0.44794655}, {'id': 'https://openalex.org/C2777025900', 'wikidata': 'https://www.wikidata.org/wiki/Q29725', 'display_name': 'Vascular endothelial growth factor', 'level': 3, 'score': 0.43880656}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.37396917}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.35044897}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.34704876}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.17397046}, {'id': 'https://openalex.org/C167734588', 'wikidata': 'https://www.wikidata.org/wiki/Q4356503', 'display_name': 'VEGF receptors', 'level': 2, 'score': 0.1286397}, {'id': 'https://openalex.org/C2778019345', 'wikidata': 'https://www.wikidata.org/wiki/Q1148337', 'display_name': 'Hepatocellular carcinoma', 'level': 2, 'score': 0.10035089}], 'mesh': [{'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011505', 'descriptor_name': 'Protein-Tyrosine Kinases', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D013964', 'descriptor_name': 'Thyroid Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000077784', 'descriptor_name': 'Axitinib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001557', 'descriptor_name': 'Benzenesulfonates', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D001557', 'descriptor_name': 'Benzenesulfonates', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002986', 'descriptor_name': 'Clinical Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077156', 'descriptor_name': 'Gefitinib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007093', 'descriptor_name': 'Imidazoles', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D007093', 'descriptor_name': 'Imidazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007191', 'descriptor_name': 'Indazoles', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D007191', 'descriptor_name': 'Indazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007211', 'descriptor_name': 'Indoles', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D007211', 'descriptor_name': 'Indoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009536', 'descriptor_name': 'Niacinamide', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D009536', 'descriptor_name': 'Niacinamide', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D009536', 'descriptor_name': 'Niacinamide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009841', 'descriptor_name': 'Oligonucleotides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004364', 'descriptor_name': 'Pharmaceutical Preparations', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010671', 'descriptor_name': 'Phenylurea Compounds', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011505', 'descriptor_name': 'Protein-Tyrosine Kinases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D048493', 'descriptor_name': 'Proto-Oncogene Proteins B-raf', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D048493', 'descriptor_name': 'Proto-Oncogene Proteins B-raf', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011725', 'descriptor_name': 'Pyridines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D011725', 'descriptor_name': 'Pyridines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011758', 'descriptor_name': 'Pyrroles', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D011758', 'descriptor_name': 'Pyrroles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011799', 'descriptor_name': 'Quinazolines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011799', 'descriptor_name': 'Quinazolines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D040262', 'descriptor_name': 'Receptors, Vascular Endothelial Growth Factor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D040262', 'descriptor_name': 'Receptors, Vascular Endothelial Growth Factor', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D000077157', 'descriptor_name': 'Sorafenib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000077210', 'descriptor_name': 'Sunitinib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013961', 'descriptor_name': 'Thyroid Gland', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D013961', 'descriptor_name': 'Thyroid Gland', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013964', 'descriptor_name': 'Thyroid Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.beem.2009.08.001', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S63781308', 'display_name': 'Best Practice & Research Clinical Endocrinology & Metabolism', 'issn_l': '1521-690X', 'issn': ['1521-690X', '1532-1908'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/19942148', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.79, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 88, 'referenced_works': ['https://openalex.org/W1523413020', 'https://openalex.org/W1847774702', 'https://openalex.org/W1964977762', 'https://openalex.org/W1965914891', 'https://openalex.org/W1967066162', 'https://openalex.org/W1969482148', 'https://openalex.org/W1982618742', 'https://openalex.org/W1985569070', 'https://openalex.org/W1986032822', 'https://openalex.org/W1986163748', 'https://openalex.org/W1986238320', 'https://openalex.org/W1986645168', 'https://openalex.org/W1998787622', 'https://openalex.org/W2007193634', 'https://openalex.org/W2009912758', 'https://openalex.org/W2017322644', 'https://openalex.org/W2018185552', 'https://openalex.org/W2025363005', 'https://openalex.org/W2028735300', 'https://openalex.org/W2031614751', 'https://openalex.org/W2034269086', 'https://openalex.org/W2039615650', 'https://openalex.org/W2040894487', 'https://openalex.org/W2043696829', 'https://openalex.org/W2051963942', 'https://openalex.org/W2052020668', 'https://openalex.org/W2059499441', 'https://openalex.org/W2070563197', 'https://openalex.org/W2071394735', 'https://openalex.org/W2073212944', 'https://openalex.org/W2074354102', 'https://openalex.org/W2076677849', 'https://openalex.org/W2076815234', 'https://openalex.org/W2077735413', 'https://openalex.org/W2077804275', 'https://openalex.org/W2079134837', 'https://openalex.org/W2079428107', 'https://openalex.org/W2081242185', 'https://openalex.org/W2089327677', 'https://openalex.org/W2091494856', 'https://openalex.org/W2096514095', 'https://openalex.org/W2096993465', 'https://openalex.org/W2097535250', 'https://openalex.org/W2099847894', 'https://openalex.org/W2102541302', 'https://openalex.org/W2104835206', 'https://openalex.org/W2106695112', 'https://openalex.org/W2109544257', 'https://openalex.org/W2111060860', 'https://openalex.org/W2112467833', 'https://openalex.org/W2112475888', 'https://openalex.org/W2116137381', 'https://openalex.org/W2118559000', 'https://openalex.org/W2119748423', 'https://openalex.org/W2125519805', 'https://openalex.org/W2125916043', 'https://openalex.org/W2126077728', 'https://openalex.org/W2128967324', 'https://openalex.org/W2130105793', 'https://openalex.org/W2130673296', 'https://openalex.org/W2139248078', 'https://openalex.org/W2140050140', 'https://openalex.org/W2140765540', 'https://openalex.org/W2140777372', 'https://openalex.org/W2141502738', 'https://openalex.org/W2147289344', 'https://openalex.org/W2149026055', 'https://openalex.org/W2151507583', 'https://openalex.org/W2153747163', 'https://openalex.org/W2154493372', 'https://openalex.org/W2155008672', 'https://openalex.org/W2158801409', 'https://openalex.org/W2166259130', 'https://openalex.org/W2222530102', 'https://openalex.org/W2241837682', 'https://openalex.org/W2243904500', 'https://openalex.org/W2247948724', 'https://openalex.org/W2249967442', 'https://openalex.org/W2250151614', 'https://openalex.org/W2252292203', 'https://openalex.org/W2266708214', 'https://openalex.org/W2281788056', 'https://openalex.org/W2307808647', 'https://openalex.org/W2337338475', 'https://openalex.org/W3172561670', 'https://openalex.org/W4238492599', 'https://openalex.org/W4244945655', 'https://openalex.org/W910853'], 'related_works': ['https://openalex.org/W44938027', 'https://openalex.org/W2613793516', 'https://openalex.org/W2332439039', 'https://openalex.org/W2150001950', 'https://openalex.org/W2135102527', 'https://openalex.org/W2134825018', 'https://openalex.org/W2069362902', 'https://openalex.org/W2049084651', 'https://openalex.org/W2036852888', 'https://openalex.org/W2019556233'], 'abstract_inverted_index': {'Protein': [0], 'tyrosine': [1], 'kinase': [2], 'inhibitors': [3], '(TKIs)': [4], 'have': [5, 31, 41, 69, 118], 'emerged': [6], 'as': [7], 'significant': [8], 'targets': [9], 'for': [10, 80, 86, 90, 103, 130], 'novel': [11, 26, 104], 'cancer': [12], 'therapies.': [13], 'For': [14], 'patients': [15, 81, 91, 132], 'with': [16, 92, 106, 122], 'differentiated': [17], 'or': [18, 94], 'medullary': [19], 'carcinomas': [20], 'unresponsive': [21], 'to': [22, 39], 'conventional': [23], 'treatments,': [24], 'multiple': [25], 'therapies': [27], 'primarily': [28], 'targeting': [29], 'angiogenesis': [30], 'entered': [32], 'clinical': [33, 87, 100], 'trials.': [34, 88], 'Partial': [35], 'response': [36], 'rates': [37], 'up': [38], '30%': [40], 'been': [42, 120], 'reported': [43, 74], 'in': [44], 'single-agent': [45], 'studies,': [46], 'but': [47], 'prolonged': [48], 'disease': [49], 'stabilisation': [50], 'is': [51], 'more': [52], 'commonly': [53], 'seen.': [54], 'The': [55], 'most': [56], 'successful': [57], 'agents': [58, 105], 'target': [59], 'the': [60], 'vascular': [61], 'endothelial': [62], 'growth': [63], 'factor': [64], 'receptors.': [65], 'Sorafenib': [66], 'and': [67, 75, 114], 'sunitinib': [68], 'had': [70], 'promising': [71], 'preliminary': [72], 'results': [73], 'are': [76], 'being': [77], 'used': [78], 'selectively': [79], 'who': [82], 'do': [83], 'not': [84], 'qualify': [85], 'Treatment': [89], 'metastatic': [93], 'advanced': [95], 'thyroid': [96, 112, 115, 127], 'carcinoma': [97], 'now': [98], 'emphasises': [99], 'trial': [101], 'opportunities': [102], 'considerable': [107], 'promise.': [108], 'Adverse': [109], 'effects': [110], 'on': [111], 'function': [113, 128], 'hormone': [116], 'metabolism': [117], 'also': [119], 'seen': [121], 'several': [123], 'TKIs,': [124], 'necessitating': [125], 'prospective': [126], 'testing': [129], 'all': [131], 'starting': [133], 'therapy.': [134]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2006989376', 'counts_by_year': [{'year': 2023, 'cited_by_count': 2}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 3}, {'year': 2016, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 3}, {'year': 2014, 'cited_by_count': 5}, {'year': 2013, 'cited_by_count': 5}, {'year': 2012, 'cited_by_count': 3}], 'updated_date': '2024-09-17T15:17:20.548171', 'created_date': '2016-06-24'}